Rapid Micro Biosystems, Inc. (NASDAQ:RPID - Get Free Report) saw a large increase in short interest in March. As of March 15th, there was short interest totalling 1,180,000 shares, an increase of 190.3% from the February 28th total of 406,500 shares. Currently, 5.8% of the shares of the stock are short sold. Based on an average daily volume of 501,000 shares, the short-interest ratio is presently 2.4 days.
Rapid Micro Biosystems Price Performance
Shares of RPID stock opened at $2.64 on Tuesday. Rapid Micro Biosystems has a one year low of $0.58 and a one year high of $4.04. The company has a market cap of $114.15 million, a P/E ratio of -2.36 and a beta of 1.08. The firm has a 50-day moving average of $2.57 and a 200-day moving average of $1.55.
Rapid Micro Biosystems (NASDAQ:RPID - Get Free Report) last posted its quarterly earnings data on Friday, February 28th. The company reported ($0.22) earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of ($0.22). Rapid Micro Biosystems had a negative net margin of 184.93% and a negative return on equity of 48.05%. The business had revenue of $8.22 million during the quarter, compared to the consensus estimate of $8.20 million. As a group, research analysts expect that Rapid Micro Biosystems will post -1.1 earnings per share for the current fiscal year.
Analyst Ratings Changes
Separately, KeyCorp assumed coverage on shares of Rapid Micro Biosystems in a research report on Wednesday, February 12th. They issued an "overweight" rating and a $8.00 price target on the stock.
Read Our Latest Report on RPID
Institutional Trading of Rapid Micro Biosystems
Hedge funds have recently added to or reduced their stakes in the business. Millennium Management LLC increased its position in Rapid Micro Biosystems by 17.6% during the 4th quarter. Millennium Management LLC now owns 61,375 shares of the company's stock valued at $55,000 after purchasing an additional 9,191 shares during the period. Citadel Advisors LLC purchased a new stake in shares of Rapid Micro Biosystems in the fourth quarter worth $65,000. Finally, Renaissance Technologies LLC raised its holdings in Rapid Micro Biosystems by 122.9% in the fourth quarter. Renaissance Technologies LLC now owns 183,087 shares of the company's stock worth $165,000 after buying an additional 100,942 shares during the last quarter. 52.60% of the stock is owned by institutional investors.
Rapid Micro Biosystems Company Profile
(
Get Free Report)
Rapid Micro Biosystems, Inc, a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services.
Further Reading
Before you consider Rapid Micro Biosystems, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Rapid Micro Biosystems wasn't on the list.
While Rapid Micro Biosystems currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.